Dr. Heba Ibrahim is the regional support and consultant for Africa and Middle East at MedDRA Maintenance and Services Organization (MedDRA MSSO).

She has over 14 years of experience as a regulator in the Egyptian Drug Authority (EDA) where she played various roles including 6 years in the Egyptian Pharmaceutical Vigilance Center (EPVC). She founded EPVC’s Signal Management Unit in 2020 and headed it until June 2023. She also volunteered and contributed to a number of international pharmacovigilance activities and initiatives.

She acted as a member of the National Working Group for the WHO global benchmarking tool (GBT) – Vigilance function for 2021/2022 where EDA was benchmarked with ML3 and designated as a WHO-Listed Authority for vaccine regulation in March 2022. She also updated the Signal Management Module of the Egyptian-GVP guidelines issued in June 2023.

She holds MSc. and Ph.D. degrees with research topics focused on data mining and Machine learning in pharmacovigilance signal detection, and her research studies have been published in prestigious ScienceDirect journals. She is also a peer reviewer of several scientific journals.